Active Biotech AB - Company Profile
Powered by 
All the sales intelligence you need on Active Biotech AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Active Biotech AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Active Biotech AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Active Biotech AB (Active Biotech) is a pharmaceutical company focused on the research and development of pharmaceuticals in therapeutic areas such as cancer and inflammatory diseases with unmet medical needs. The company specializes in developing small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Active Biotech focuses on pharmaceutical research and development in therapeutic areas with high medical needs, particularly where the immune system plays a significant role. The company's project portfolio includes small, orally active immunomodulatory molecules and antibody-based immunotherapy for treating cancer and inflammatory diseases. The major projects include tasquinimod for hematological malignancies like myelofibrosis and multiple myeloma, laquinimod for inflammatory eye disorders, and naptumomab for solid tumors. The company collaborates with institutions such as Oncode Institute, Erasmus MC, MD Anderson Cancer Center, and Stanford University to advance these projects. The R&D activities of Active Biotech AB are managed through collaborations with various research institutions and universities. These collaborations are responsible for conducting clinical studies, exploring new indications, and developing the company's pharmaceutical projects. The company collaborates with multiple research institutions, including Erasmus MC, MD Anderson Cancer Center, and Stanford University, but specific R&D centers are not mentioned. In FY2024, the company spent SEK26.7 million on its R&D activities.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer